171 related articles for article (PubMed ID: 27611825)
1. Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series.
Ball MW; Harris KT; Schwen ZR; Mullins JK; Han M; Walsh PC; Partin AW; Epstein JI
BJU Int; 2017 Mar; 119(3):444-448. PubMed ID: 27611825
[TBL] [Abstract][Full Text] [Related]
2. Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study.
Kwon YS; Ha YS; Modi PK; Salmasi A; Parihar JS; Patel N; Faiena I; May M; Lee DI; Llukani E; Patrick T; Rha KH; Ahlering T; Skarecky D; Ahn H; Choi SK; Park S; Jeon SS; Ou YC; Eun D; Manucha V; Albala D; Badani K; Yuh B; Ruel N; Kim TH; Kwon TG; Marchalik D; Hwang J; Kim WJ; Kim IY
BMC Urol; 2015 Aug; 15():79. PubMed ID: 26231860
[TBL] [Abstract][Full Text] [Related]
3. Pathologic implications of prostatic anterior fat pad.
Jeong J; Choi EY; Kang DI; Ercolani M; Lee DH; Kim WJ; Kim IY
Urol Oncol; 2013 Jan; 31(1):63-7. PubMed ID: 21396837
[TBL] [Abstract][Full Text] [Related]
4. [Lymph Node Metastasis to the Prostatic Anterior Fat Pad in the Patients Treated with Prostatectomy].
Shimizu Y; Ogawa K; Kida K; Tsuchihashi K; Kanamaru S; Ishihara M; Hashimoto K; Ito N
Hinyokika Kiyo; 2018 Sep; 64(9):359-363. PubMed ID: 30369226
[TBL] [Abstract][Full Text] [Related]
5. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study.
Kim IY; Modi PK; Sadimin E; Ha YS; Kim JH; Skarecky D; Cha DY; Wambi CO; Ou YC; Yuh B; Park S; Llukani E; Albala DM; Wilson T; Ahlering T; Badani K; Ahn H; Lee DI; May M; Kim WJ; Lee DH
J Urol; 2013 Aug; 190(2):527-34. PubMed ID: 23485503
[TBL] [Abstract][Full Text] [Related]
6. [Landscape and metastases of the lymph nodes in prostatic anterior fat pad at radical prostatectomy].
Zhao DW; Zhou ZH; Zhao JL; Chen D; Yang ZY; Wang J; Long XB; Zhang YJ; Yang P; Cao Y; Li JB; Zhou FJ; Li YH
Zhonghua Wai Ke Za Zhi; 2022 Nov; 60(11):999-1003. PubMed ID: 36323582
[No Abstract] [Full Text] [Related]
7. Presence of lymph nodes and metastasis within prostatic anterior fat pad in radical prostatectomy patients: A single Chinese institution experience and literature review.
Hu M; Liao J; Cai W; Ling H; Wu D; Xu X; Zhu Q; Ye L
Eur J Surg Oncol; 2023 Dec; 49(12):107112. PubMed ID: 37832178
[TBL] [Abstract][Full Text] [Related]
8. Metastatic Involvement of the Prostatic Anterior Fat Pad: Implications for the Pathologist.
Lopez-Hisijos N; Genco I; Gorbonos A; Pambuccian SE; Barkan GA
Am J Clin Pathol; 2018 Jul; 150(2):130-136. PubMed ID: 29893778
[TBL] [Abstract][Full Text] [Related]
9. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
[TBL] [Abstract][Full Text] [Related]
10. Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?
Kluth LA; Xylinas E; Rieken M; Chun FK; Fajkovic H; Becker A; Karakiewicz PI; Passoni N; Herman M; Lotan Y; Seitz C; Schramek P; Remzi M; Loidl W; Guillonneau B; Rouprêt M; Briganti A; Scherr DS; Graefen M; Tewari AK; Shariat SF
Urol Oncol; 2014 Jan; 32(1):47.e1-8. PubMed ID: 24055425
[TBL] [Abstract][Full Text] [Related]
11. Impact of prostatic anterior fat pads with lymph node staging in prostate cancer.
Weng WC; Huang LH; Hsu CY; Tung MC; Yang CK; Jin JS; Ou YC; Yang SF
J Cancer; 2018; 9(18):3361-3365. PubMed ID: 30271497
[No Abstract] [Full Text] [Related]
12. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
[TBL] [Abstract][Full Text] [Related]
13. KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.
Lunger L; Retz M; Bandur M; Souchay M; Vitzthum E; Jäger M; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Koll F; Gschwend JE; Nawroth R; Heck MM
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):362-369. PubMed ID: 32978525
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis.
Passoni NM; Fajkovic H; Xylinas E; Kluth L; Seitz C; Robinson BD; Rouprêt M; Chun FK; Lotan Y; Roehrborn CG; Crivelli JJ; Karakiewicz PI; Scherr DS; Rink M; Graefen M; Schramek P; Briganti A; Montorsi F; Tewari A; Shariat SF
BJU Int; 2014 Oct; 114(4):503-10. PubMed ID: 24053552
[TBL] [Abstract][Full Text] [Related]
15. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of histomorphologic features of lymph node metastases in prostate cancer patients treated with radical prostatectomy: A single center study.
Alhamar M; Jabbar A; Deebajah M; Diaz M; Alanee S; Hassan O; Williamson SR; Schultz D; Gupta N
Urol Oncol; 2021 Dec; 39(12):829.e1-829.e8. PubMed ID: 33985876
[TBL] [Abstract][Full Text] [Related]
17. Analysis of regional lymph nodes in periprostatic fat following robot-assisted radical prostatectomy.
Yuh B; Wu H; Ruel N; Wilson T
BJU Int; 2012 Feb; 109(4):603-7. PubMed ID: 21851536
[TBL] [Abstract][Full Text] [Related]
18. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
19. Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer.
Mandel P; Kriegmair MC; Bogdan K; Boehm K; Budäus L; Graefen M; Huland H; Tilki D
Eur Urol Focus; 2017 Apr; 3(2-3):248-255. PubMed ID: 28753755
[TBL] [Abstract][Full Text] [Related]
20. Biochemical relapse predictive factors in patients with lymph node metastases during radical prostatectomy.
Mandoorah Q; Benamran D; Pinar U; Seisen T; Abdessater M; Iselin C; Rouprêt M
Prog Urol; 2022 Dec; 32(16):1462-1468. PubMed ID: 35941008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
